DexCom, Inc. DexCom, Inc.

DexCom, Inc.

DXCM

주식 순위 #794
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
주가
$80.84
마지막 동기화: 2026-10-21
시가총액
$30.51B
변동 (1일)
-5.71%
변동 (1년)
14.34%
국가
US
거래 DexCom, Inc. (DXCM)

카테고리

Healthcare
DexCom, Inc. (DXCM)의 주가 이력
최고 종가: $85.03 (2026-10-01 기준)

최저 종가: $2.62 (2005-04-01 기준)
DexCom, Inc.의 주가 이력 (2005 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 8.59%
2025 -15.80%
2024 -34.77%
2023 4.53%
2022 -15.88%
2021 56.71%
2020 61.13%
2019 81.99%
2018 106.52%
2017 -8.67%
2016 -24.00%
2015 51.66%
2014 60.01%
2013 152.75%
2012 61.44%
2011 -34.72%
2010 71.04%
2009 169.94%
2008 -67.70%
2007 -20.46%
2006 -27.06%
2005 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$100.56 -21.41%
US
$93.07 -2.95%
IE
$297.13 -23.49%
US
$44.47 -57.18%
US
$46.69 -18.50%
DE